Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Costs of predicting IDDM.

Hahl J, Simell T, Ilonen J, Knip M, Simell O.

Diabetologia. 1998 Jan;41(1):79-85.

PMID:
9498634
2.

A simulation model for estimating direct costs of type 1 diabetes prevention.

Hahl J, Simell T, Kupila A, Keskinen P, Knip M, Ilonen J, Simell O.

Pharmacoeconomics. 2003;21(5):295-303.

PMID:
12627983
3.

Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort.

Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hämäläinen AM, Korhonen S, Kimpimäki T, Sjöroos M, Ilonen J, Knip M, Simell O; Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland..

Diabetologia. 2001 Mar;44(3):290-7.

PMID:
11317658
4.

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Näntö-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipilä JI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O.

Lancet. 2008 Nov 15;372(9651):1746-55. doi: 10.1016/S0140-6736(08)61309-4. Epub 2008 Sep 22.

PMID:
18814906
5.
6.

[Predictive genetic screening for type-1 diabetes in the Hungarian population].

Hermann R, Soltész G.

Orv Hetil. 2004 Feb 15;145(7):337-42. Hungarian.

PMID:
15049049
7.

In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.

Metcalfe KA, Hitman GA, Fennessy MJ, McCarthy MI, Tuomilehto J, Tuomilehto-Wolf E.

Diabetologia. 1995 Oct;38(10):1223-9.

PMID:
8690176
8.

Immunogenetic determinants and prediction of IDDM in French schoolchildren.

Lévy-Marchal C, Dubois F, Noël M, Tichet J, Czernichow P.

Diabetes. 1995 Sep;44(9):1029-32.

PMID:
7657024
9.
10.

Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.

Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG.

Diabetes Care. 1997 Jun;20(6):965-70.

PMID:
9167107
11.
12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
13.

[Cost of insulin-dependent diabetes vs cost of its prevention].

Vardi P, Weitzman S, Shavit T.

Harefuah. 1995 Mar 1;128(5):281-5, 335. Hebrew.

PMID:
7744348
14.
15.

Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.

Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, d'Annunzio G, Bonifacio E; Pediatric Italian Study Group of Prediabetes..

Diabetes Care. 2001 Jul;24(7):1210-6.

PMID:
11423504
16.

Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.

Kukko M, Virtanen SM, Toivonen A, Simell S, Korhonen S, Ilonen J, Simel O, Knip M.

Diabetes Care. 2004 Mar;27(3):676-81.

PMID:
14988284
17.

[Prediction of insulin-dependent diabetes mellitus in children of first-degree relatives of diabetic patients].

Cinek O, Kolousková S, Pechová M, Sumník Z, Sedláková P, Bendukidze N, Ivasková E, Snajderová M, Vavrinec J.

Cas Lek Cesk. 2001 Aug;140(16):492-6. Czech.

PMID:
11678027
18.

First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.

Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkilä S, Savolainen H, Arvilommi P, Simell T, Ilonen J, Knip M, Simell O.

Diabetologia. 2002 Dec;45(12):1639-48. Epub 2002 Oct 30.

PMID:
12488953
19.

[Cost benefit of screening for type 1 diabetes. A futuristic scenario].

Lévy-Marchal C.

Diabete Metab. 1993 Dec;19(5 Suppl):538-45. French.

PMID:
8206195
20.

A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E.

Diabetologia. 1994 Sep;37(9):937-44.

PMID:
7806025

Supplemental Content

Support Center